Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Authors: Modvig, S., Madsen, H. O., Siitonen, S. M., Rosthøj, S., Tierens, A., Juvonen, V., Osnes, L.T.N., Vålerhaugen, H., Hultdin, M., Thörn, I., Matuzeviciene, R., Stoskus, M., Marincevic, M., Fogelstrand, L., Lilleorg, A., Toft, N., Jónsson, O. G., Pruunsild, K., Vaitkeviciene, G., Vettenranta, K., Lund, B., Abrahamsson, J., Schmiegelow, K., Marquart, H. V.

Source: Leukemia. 33(6):1324-1336

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193381685.0x000001&indx=1&recIds=ETOCvdc_100193381685.0x000001

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry

Authors: Alm, S. J., Engvall, C., Asp, J., Palmqvist, L., Abrahamsson, J., Fogelstrand, L.

Source: INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 39(2):121-128

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383529783&indx=1&recIds=ETOCRN383529783

Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice

Authors: Staffas, A., Arabanian, L. S., Wei, S. Y., Jansson, A., Stahlman, S., Johansson, P., Fogelstrand, L., Cammenga, J., Kuchenbauer, F., Palmqvist, L.

Source: ONCOGENE -BASINGSTOKE-. 36(11):1516-1524

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN383508330&indx=1&recIds=ETOCRN383508330

P543: TARGETING SAMHD1 WITH HYDROXYUREA IN FIRST-LINE CYTARABINE-BASED THERAPY OF NEWLY DIAGNOSED ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE HEAT-AML TRIAL

Authors: Jädersten, M., Lilienthal, I., Tsesmetzis, N., Lourda, M., Bengtzén, S., Bohlin, A., Arnroth, C., Erkers, T., Seashore-Ludlow, B., Giraud, G., Barkhordar, G. S., Tao, S., Fogelstrand, L., Saft, L., Östling, P., Schinazi, R., Kim, B., Schaller, T., Juliusson, G., Deneberg, S., Lehmann, S., Rassidakis, G., Höglund, M., Henter, J.-I., Herold, N.

Source: HemaSphere. 6:442-443

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100165710065.0x000001&indx=1&recIds=ETOCvdc_100165710065.0x000001

Early hematopoiesis in multiple sclerosis patients

Authors: Jons, D., Kneider, M., Fogelstrand, L., Jeppsson, A., Jacobsson, S., Andersen, O.

Source: JOURNAL OF NEUROIMMUNOLOGY. 299:158-163

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN382968396&indx=1&recIds=ETOCRN382968396

Exploring the heterogeneity of the hematopoietic stem and progenitor cell pool in cord blood: simultaneous staining for side population, aldehyde dehydrogenase activity, and CD34 expression

Authors: Frndberg, S., Borestrm, C., Li, S., Fogelstrand, L., Palmqvist, L.

Source: TRANSFUSION -PHILADELPHIA-. 55(6):1283-1289

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN374795737&indx=1&recIds=ETOCRN374795737

alpha 7 Nicotinic Acetylcholine Receptor Is Expressed in Human Atherosclerosis and Inhibits Disease in Mice-Brief Report

Authors: Johansson, M.E., Ulleryd, M.A., Bernardi, A., Lundherg, A.M., Andersson, A., Folkersen, L., Fogelstrand, L., Islander, U., Yan, Z.-q., Hansson, G.K.

Source: ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 34(12):2632-2636

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN364168195&indx=1&recIds=ETOCRN364168195

Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-all treated according to the NOPHO ALL-1992 and ALL-2000 protocols

Authors: Fogelstrand, L., Staffas, A., Wasslavik, C., Sjgren, H., Sderhll, S., Frost, B. M., Forestier, E., Degerman, S., Behrendtz, M., Heldrup, J.

Source: PEDIATRIC BLOOD AND CANCER. 61(3):424-430

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN345883804&indx=1&recIds=ETOCRN345883804

Glucose impairs B-1 cell function in diabetes

Authors: Jennbacken, K., Sthlman, S., Grahnemo, L., Wiklund, O., Fogelstrand, L.

Source: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 174(1):129-138

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN338787740&indx=1&recIds=ETOCRN338787740

Rip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation

Authors: Levin, M.C., Jirholt, P., Wramstedt, A., Johansson, M.E., Lundberg, A.M., Trajkovska, M.G., Stahlman, M., Fogelstrand, P., Brisslert, M., Fogelstrand, L.

Source: CIRCULATION RESEARCH. 109(11):1210-1218

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN302489920&indx=1&recIds=ETOCRN302489920

LDL-associated apolipoprotein J and lysozyme are associated with atherogenic properties of LDL found in type 2 diabetes and the metabolic syndrome

Authors: Pettersson, C., Karlsson, H., Sthlman, M., Larsson, T., Fagerberg, B., Lindahl, M., Wiklund, O., Born, J., Fogelstrand, L.

Source: JOURNAL OF INTERNAL MEDICINE -OXFORD-. 269(3):306-321

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN286240962&indx=1&recIds=ETOCRN286240962

Phosphoinositide 3-Kinase p110 delta Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses

Authors: Durand, C.A., Hartvigsen, K., Fogelstrand, L., Kim, S., Iritani, S., Vanhaesebroeck, B., Witztum, J.L., Puri, K.D., Gold, M.R.

Source: JOURNAL OF IMMUNOLOGY -BETHESDA-. 183(9):5673-5684

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN259536830&indx=1&recIds=ETOCRN259536830

Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans

Authors: Chou, M.-Y., Fogelstrand, L., Hartvigsen, K., Hansen, L.F., Woelkers, D., Shaw, P.X., Choi, J., Perkmann, T., Backhed, F., Miller, Y.I.

Source: JOURNAL OF CLINICAL INVESTIGATION. 119(5):1335-1349

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN250849757&indx=1&recIds=ETOCRN250849757

Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages

Authors: Haversen, L., Danielsson, K. N., Fogelstrand, L., Wiklund, O.

Source: ATHEROSCLEROSIS -AMSTERDAM-. 202(2):382-393

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN244176249&indx=1&recIds=ETOCRN244176249

Increased lipolysis by secretory phospholipase A2 group V of lipoproteins in diabetic dyslipidaemia

Authors: Pettersson, C., Fogelstrand, L., Rosengren, B., Stahlman, S., Hurt-Camejo, E., Fagerberg, B., Wiklund, O.

Source: JOURNAL OF INTERNAL MEDICINE -OXFORD-. 264(2):155-165

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN232457260&indx=1&recIds=ETOCRN232457260

Oxidation-specific epitopes are important targets of innate immunity

Authors: Chou, M. Y., Hartvigsen, K., Hansen, L. F., Fogelstrand, L., Shaw, P. X., Boullier, A., Binder, C. J., Witztum, J. L.

Source: JOURNAL OF INTERNAL MEDICINE -OXFORD-. 263(5):479-488

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN227240621&indx=1&recIds=ETOCRN227240621

Natural Antibodies in Murine Atherosclerosis

Authors: Binder, C.J., Chou, M.-Y., Fogelstrand, L., Hartvigsen, K., Shaw, P.X., Boullier, A., Witztum, J.L.

Source: CURRENT DRUG TARGETS. 9(3):190-195

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN225948596&indx=1&recIds=ETOCRN225948596

Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance (Short Communication)

Authors: Fogelstrand, L.

Source: DIABETOLOGIA. 47(11):1948-1952

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN161625137&indx=1&recIds=ETOCRN161625137

Circulating soluble CD44 is higher among women than men and is not associated with cardiovascular risk factors or subclinical atherosclerosis

Authors: Sjöberg, S., Fogelstrand, L., Hulthe, J., Fagerberg, B. r., Krettek, A.

Source: METABOLISM. 54(2):139-141

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN162481495&indx=1&recIds=ETOCRN162481495

This result is not displayed to guests.
Login for full access.